logo

For the Inventor, By the Inventor

Omaha, NE, United States of America

Serguei V Vinogradov

This inventor holds 6 USPTO granted patents and 2 published patent applications. Top assignees: The Board of Regents of the University of Nebraska, Northwestern University, Supratek Pharma Inc.. Active years: 2000-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Serguei V Vinogradov. Retrieved from https://idiyas.com/inventor/serguei-v-vinogradov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 66.7

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 23(Granted Patents)


Location History:

  • Moscow, SU (2000)
  • Omaha, NE (2011)
  • Omaha, NE (US) (2001 - 2022)

Company Filing History:

goldMedal4 out of 968 
 
The Board of Regents of the University of Nebraska
 patents
silverMedal2 out of 2,217 
 
Northwestern University
 patents
bronzeMedal2 out of 30 
 
Supratek Pharma Inc.
 patents
where one patent can have more than one assignee

Years Active: 2000-2022

Loading Chart...
6 patents (USPTO):Explore Patents
1. 11261237 - Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection (2022-03-01),
2. 10081668 - Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection (2018-09-25),
3. 8168222 - Amphiphilic polymer-protein conjugates and methods of use thereof (2012-05-01),
4. 8017151 - Amphiphilic polymer-protein conjugates and methods of use thereof (2011-09-13),
5. 6316505 - Pharmaceutical compositions comprising fluorinated co-polymers (2001-11-13),
6. 6054492 - Fluorinated copolymeric pharmaceutical adjuncts (2000-04-25),

Title: The Innovative Contributions of Serguei V Vinogradov

Introduction

Serguei V Vinogradov is a prominent inventor based in Omaha, NE (US). He has made significant contributions to the field of biomedical research, particularly in the development of novel therapeutic agents. With a total of 6 patents to his name, Vinogradov's work focuses on addressing critical health challenges.

Latest Patents

Vinogradov's latest patents include the development of modified pigment epithelium-derived factor (PEDF) peptides. These peptides are designed for treating neovascular diseases, inflammatory diseases, cancer, and for providing cytoprotection. The disclosed inventions encompass modified PEDF peptides, particulate carrier prodrugs, and pharmaceutical compositions that utilize these peptides. These innovations may be employed in treating various diseases and disorders that can benefit from anti-angiogenic agents, anti-tumorigenic agents, anti-fibrotic agents, chemotherapy-protecting agents, and immune-stimulating agents.

Career Highlights

Throughout his career, Vinogradov has worked with notable organizations, including the Board of Regents of the University of Nebraska and Supratek Pharma Inc. His research and inventions have contributed to advancements in medical treatments and therapeutic strategies.

Collaborations

Vinogradov has collaborated with esteemed colleagues such as Alexander Victorovich Kabanov and Jack Henkin. These partnerships have further enhanced the impact of his research and innovations in the biomedical field.

Conclusion

Serguei V Vinogradov's contributions to the field of biomedical research through his innovative patents and collaborations highlight his commitment to improving health outcomes. His work continues to pave the way for new therapeutic approaches in treating complex diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…